New approaches to the discovery of treatments for major unmet medical needs

Phenotypic drug discovery (PDD) has lower costs and is showing higher success rates than traditional target-based approaches, improving health outcomes and lowering the cost of new medications - see more. Our multidisciplinary research group is undertaking PDD in areas of cancer, fibrosis (organ failure) and autoimmune disease. Contact Associate Professor Bernard Flynn for more project details.

New approaches to the discovery of treatments for major unmet medical needs

Enhanced research experiences